InsidersTradesSigma
큐리언트 Stock: price and management transactions · South Korea · DART (FSS)
Follow the 큐리언트 share price and the full insider trade history of the company, a publicly traded company based in South Korea. Shares trade on KR KR, under the supervision of DART (FSS). Operating in the Health Care sector, 큐리언트 has recorded 11 public disclosures. Market capitalisation: €560.4bn. The latest transaction was disclosed on 23 June 2026 (Sale). Among the most active insiders: 유암코키스톤구조혁신기업재무안정사모투자. Every trade is free.
8
Insider Decl.
n/a
Thresholds
€200,698
5 ops.
Buy Volume
n/a
2 ops.
Sell Volume
31Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 26,539 of 27,969 companies
15.8
score / 100
Value22
Quality9
FCF yld-5.1%
Earn yld-4.7%
EV/EBITDA·
ROE-75%
Gross mgn13%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 23 June 2026
Declarations11 total
Other
Other(filed)
Other
Other(filed)
Other
Other(filed)
2,000 sharesKRXDART:20260623000267
11 of 11 declarations
About 큐리언트
큐리언트 is a healthcare and pharmaceutical company listed on the XKRX market. It focuses on developing innovative treatments for various diseases.